Juvenile idiopathic arthritis in Jordan: single center experience

Table 3 Articular and extraarticular clinical manifestations at presentation

	Oligoarticular JIA n (%)	Polyarticular JIA n (%)	Systemic JIA n (%)	P-value
TMJ	4 (3.4%)	0 (0%)	0 (0%)	n/a
Cervical	0 (0%)	0 (0%)	0 (0%)	n/a
Shoulder	0 (0%)	0 (0%)	0 (0%)	n/a
Elbow	24 (21%)	4 (15%)	10 (28%)	0.48
Wrist	14 (12%)	3 (11.5%)	20 (55.5%)	< 0.001
MCP	0 (0%)	4 (15%)	1 (2.7%)	n/a
PIP	1 (0.8%)	3 (11.5%)	2 (5.5%)	n/a
Hip	2 (1.6%)	1 (4%)	0 (0%)	n/a
Knee	92 (80%)	26 (100%)	36 (100%)	< 0.001
Ankle	24 (21%)	8 (30%)	18 (50%)	< 0.01
Fever	0 (0%)	0 (0%)	36 (100%)	n/a
Rash	0 (0%)	0 (0%)	24 (66.6%)	n/a
Lymphadenopathy	0 (0%)	0 (0%)	2 (5.5%)	n/a
Hepatosplenomegaly	0 (0%)	0 (0%)	0 (0%)	n/a
Serositis	0 (0%)	0 (0%)	2 (5.5%)	n/a
Uveitis	25 (21.7%)	3 (11.5%)	1 (2.7%)	0.02
MAS	0 (0%)	0 (0%)	2 (5.5%)	n/a

P-values are based on the Chi-square test performed to assess the difference in the distribution of each manifestation between the subgroups. n/a: not applicable; where there were not enough cases in each subgroup to perform the analysis. p is significant for less than 0.05
TMJ temporomandibular joint, MCP metacarpophalangeal joint, PIP proximal interphalangeal joint, MAS macrophage activation syndrome, n/a not applicable

ISSN: 1546-0096